The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis

M. A. Birchall, J. C. Henderson, J. M. Studham, I. Phillips, N. B. Pride, R. W. Fuller

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The mechanism of action of topical intranasal steroids is obscure. To investigate this, we have studied the effects of a topical intranasal corticosteroid, fluticasone propionate on nasal airflow resistance (Rnaw), secretions, cytological smears and symptoms. Fluticasone propionate aqueous nasal spray was given to 11 patients with perennial allergic rhinitis in a double-blind, placebo-controlled study. On each day, patients were challenged with ascending doses of histamine. Rnaw, secretion volume, total protein, mucin, lysozyme and albumin were measured. Nasal smears were taken and sneezes counted. Diary card data were collected for both treatment periods. There was a significant, dose-related increase in Rnaw and sneezing on histamine challenge. A single dose of fluticasone had no effect on any parameter. After 4 weeks of treatment, resistance measurements were reduced (post-challenge g.m.2.8 cmH2O/l/s.Q1-Q3 1.6-4.8; placebo 4.2, 2.9-5.3: P < 0.0001) as were baseline secretion volumes (mean 2.4 ml/5 min, c.i.1.9-3.0; placebo 3.3, 2.8-3.8: P < 0.05). Eosinophil counts were suppressed (fluticasone 5.8%, c.i. 4.0-15.7; placebo 23.3%, 12.4-34.1: P < 0.05) and the composite symptom score reduced (P < 0.05). Fluticasone has long-term effects on the nasal response to histamine in perennial allergic rhinitis and part of this effect is likely to be vascular.

Original languageEnglish (US)
Pages (from-to)204-210
Number of pages7
JournalClinical Otolaryngology and Allied Sciences
Volume20
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Rhinitis, Allergic, Perennial
Histamine
Nose
Placebos
Sneezing
Nasal Sprays
Mucins
Muramidase
Eosinophils
Blood Vessels
Albumins
Adrenal Cortex Hormones
Steroids
Fluticasone
Therapeutics
Proteins

Keywords

  • Cytology
  • Eosinophil
  • Fluticasone
  • Histamine
  • Lysozyme
  • Nasal Vessels
  • Secretion
  • Steroid

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Birchall, M. A., Henderson, J. C., Studham, J. M., Phillips, I., Pride, N. B., & Fuller, R. W. (1995). The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis. Clinical Otolaryngology and Allied Sciences, 20(3), 204-210.

The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis. / Birchall, M. A.; Henderson, J. C.; Studham, J. M.; Phillips, I.; Pride, N. B.; Fuller, R. W.

In: Clinical Otolaryngology and Allied Sciences, Vol. 20, No. 3, 1995, p. 204-210.

Research output: Contribution to journalArticle

Birchall, MA, Henderson, JC, Studham, JM, Phillips, I, Pride, NB & Fuller, RW 1995, 'The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis', Clinical Otolaryngology and Allied Sciences, vol. 20, no. 3, pp. 204-210.
Birchall, M. A. ; Henderson, J. C. ; Studham, J. M. ; Phillips, I. ; Pride, N. B. ; Fuller, R. W. / The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis. In: Clinical Otolaryngology and Allied Sciences. 1995 ; Vol. 20, No. 3. pp. 204-210.
@article{e265c3c61be84fc4b89f4ef60d6d5afd,
title = "The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis",
abstract = "The mechanism of action of topical intranasal steroids is obscure. To investigate this, we have studied the effects of a topical intranasal corticosteroid, fluticasone propionate on nasal airflow resistance (Rnaw), secretions, cytological smears and symptoms. Fluticasone propionate aqueous nasal spray was given to 11 patients with perennial allergic rhinitis in a double-blind, placebo-controlled study. On each day, patients were challenged with ascending doses of histamine. Rnaw, secretion volume, total protein, mucin, lysozyme and albumin were measured. Nasal smears were taken and sneezes counted. Diary card data were collected for both treatment periods. There was a significant, dose-related increase in Rnaw and sneezing on histamine challenge. A single dose of fluticasone had no effect on any parameter. After 4 weeks of treatment, resistance measurements were reduced (post-challenge g.m.2.8 cmH2O/l/s.Q1-Q3 1.6-4.8; placebo 4.2, 2.9-5.3: P < 0.0001) as were baseline secretion volumes (mean 2.4 ml/5 min, c.i.1.9-3.0; placebo 3.3, 2.8-3.8: P < 0.05). Eosinophil counts were suppressed (fluticasone 5.8{\%}, c.i. 4.0-15.7; placebo 23.3{\%}, 12.4-34.1: P < 0.05) and the composite symptom score reduced (P < 0.05). Fluticasone has long-term effects on the nasal response to histamine in perennial allergic rhinitis and part of this effect is likely to be vascular.",
keywords = "Cytology, Eosinophil, Fluticasone, Histamine, Lysozyme, Nasal Vessels, Secretion, Steroid",
author = "Birchall, {M. A.} and Henderson, {J. C.} and Studham, {J. M.} and I. Phillips and Pride, {N. B.} and Fuller, {R. W.}",
year = "1995",
language = "English (US)",
volume = "20",
pages = "204--210",
journal = "Clinical Otolaryngology",
issn = "1749-4478",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis

AU - Birchall, M. A.

AU - Henderson, J. C.

AU - Studham, J. M.

AU - Phillips, I.

AU - Pride, N. B.

AU - Fuller, R. W.

PY - 1995

Y1 - 1995

N2 - The mechanism of action of topical intranasal steroids is obscure. To investigate this, we have studied the effects of a topical intranasal corticosteroid, fluticasone propionate on nasal airflow resistance (Rnaw), secretions, cytological smears and symptoms. Fluticasone propionate aqueous nasal spray was given to 11 patients with perennial allergic rhinitis in a double-blind, placebo-controlled study. On each day, patients were challenged with ascending doses of histamine. Rnaw, secretion volume, total protein, mucin, lysozyme and albumin were measured. Nasal smears were taken and sneezes counted. Diary card data were collected for both treatment periods. There was a significant, dose-related increase in Rnaw and sneezing on histamine challenge. A single dose of fluticasone had no effect on any parameter. After 4 weeks of treatment, resistance measurements were reduced (post-challenge g.m.2.8 cmH2O/l/s.Q1-Q3 1.6-4.8; placebo 4.2, 2.9-5.3: P < 0.0001) as were baseline secretion volumes (mean 2.4 ml/5 min, c.i.1.9-3.0; placebo 3.3, 2.8-3.8: P < 0.05). Eosinophil counts were suppressed (fluticasone 5.8%, c.i. 4.0-15.7; placebo 23.3%, 12.4-34.1: P < 0.05) and the composite symptom score reduced (P < 0.05). Fluticasone has long-term effects on the nasal response to histamine in perennial allergic rhinitis and part of this effect is likely to be vascular.

AB - The mechanism of action of topical intranasal steroids is obscure. To investigate this, we have studied the effects of a topical intranasal corticosteroid, fluticasone propionate on nasal airflow resistance (Rnaw), secretions, cytological smears and symptoms. Fluticasone propionate aqueous nasal spray was given to 11 patients with perennial allergic rhinitis in a double-blind, placebo-controlled study. On each day, patients were challenged with ascending doses of histamine. Rnaw, secretion volume, total protein, mucin, lysozyme and albumin were measured. Nasal smears were taken and sneezes counted. Diary card data were collected for both treatment periods. There was a significant, dose-related increase in Rnaw and sneezing on histamine challenge. A single dose of fluticasone had no effect on any parameter. After 4 weeks of treatment, resistance measurements were reduced (post-challenge g.m.2.8 cmH2O/l/s.Q1-Q3 1.6-4.8; placebo 4.2, 2.9-5.3: P < 0.0001) as were baseline secretion volumes (mean 2.4 ml/5 min, c.i.1.9-3.0; placebo 3.3, 2.8-3.8: P < 0.05). Eosinophil counts were suppressed (fluticasone 5.8%, c.i. 4.0-15.7; placebo 23.3%, 12.4-34.1: P < 0.05) and the composite symptom score reduced (P < 0.05). Fluticasone has long-term effects on the nasal response to histamine in perennial allergic rhinitis and part of this effect is likely to be vascular.

KW - Cytology

KW - Eosinophil

KW - Fluticasone

KW - Histamine

KW - Lysozyme

KW - Nasal Vessels

KW - Secretion

KW - Steroid

UR - http://www.scopus.com/inward/record.url?scp=0029083757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029083757&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 204

EP - 210

JO - Clinical Otolaryngology

JF - Clinical Otolaryngology

SN - 1749-4478

IS - 3

ER -